Top 80 alternative sites to formatherapeutics.com
-
relaytx.com
-
forma.ai
-
sqzbiotech.com
-
adaptimmune.com
-
atossatherapeutics.com
-
rapt.com
-
arcturusrx.com
-
abcentra.com
-
chinooktx.com
-
travere.com
-
cardiffoncology.com
-
connectbiopharm.com
-
eurekatherapeutics.com
-
logicbio.com
-
geron.com
-
kartosthera.com
-
prilenia.com
-
jubilanttx.com
-
ocugen.com
-
blackthornrx.com
-
tessacell.com
-
insmed.com
-
lumosa.com.tw
-
zogenix.com
-
orphomed.com
-
translate.bio
-
oysterpointrx.com
-
vectivbio.com
-
arvinas.com
-
imv-inc.com
-
canprevent.com
-
g1therapeutics.com
-
zikani.com
-
viewpointtherapeutics.com
-
vivoryon.com
-
chiasma.com
-
medicago.com
-
qedtx.com
-
phathompharma.com
-
birchbiomed.com
-
odonate.com
-
cariboubio.com
-
ikenaoncology.com
-
serestherapeutics.com
-
quoruminnovations.com
-
corvuspharma.com
-
iksuda.com
-
i-mabbiopharma.com
-
azurrx.com
-
soligenix.com
-
kezarlifesciences.com
-
interna-technologies.com
-
oncternal.com
-
nspharma.com
-
harpoontx.com
-
altimmune.com
-
epizyme.com
-
khondrion.com
-
gammadeltatx.com
-
oculis.com
-
sutura.com
-
viridiantherapeutics.com
-
alnylam.ca
-
qolmed.com
-
vescortx.com
-
akebia.com
-
cellectis.com
-
lipocine.com
-
alkahest.com
-
egetis.com
-
glycadia.com
-
mtem.com
-
oncopeptides.com
-
avidiabank.com
-
glenmede.com
-
brainsell.com
-
slaneirishwhiskey.com
-
adkgroup.com
-
alku.com
-
korbel.com
Relay Therapeutics
Relay Therapeutics® puts protein motion at the heart of **** discovery to dramatically expand therapeutic possibilities.
Automated Sales Compensation for the Modern Enterprise | Forma
Elevate your sales compensation team. Retain your top sales talent. Save millions. Forma.ai is everything you ever wanted from ICM software.
Author: Dr Robert Bieshaar Snr Director; Worldwide Sales Incentive Compensation; Autodesk
SQZ Biotech
Adaptimmune Therapeutics plc
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
Atossa Therapeutics - A Clinical-Stage Biopharmaceutical Company
Atossa Therapeutics is a clinical-stage biopharmaceutical company focusing on **** cancer treatment and other **** conditions.
Homepage - RAPT Therapeutics
RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold mission—to conquer cancer and inflammatory disease in our lifetime. Our cutting-edge science is fully focused on developing **** therapeutics that intelligently target key drivers of the immune system to transform the treatment of cancer and inflammation, and improve and empower countless lives. Join us …
Arcturus Therapeutics
Arcturus Therapeutics is a clinical-stage messenger RNA medicines company focused on development and distribution of therapeutics for rare diseases & vaccines.
Abcentra - Therapeutics
Abcentra is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for cardiovascular and inflammatory diseases.
Chinook Therapeutics | Atrasentan
Chinook is a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases.
Travere Therapeutics
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
Author: Superadmin
Oncology Therapeutics - Cardiff Oncology
Cardiff Oncology is a clinical-stage company with the singular mission of developing new oncology therapeutic options for cancer patients.
Connect Biopharma - Next-Generation Therapeutics for T Cell-Driven Inflammatory Diseases
Connect Biopharma is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research.
Eureka Therapeutics | ARTEMIS™ | E-ALPHA® | T-cell therapies
Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.
LogicBio Therapeutics - Pioneering Genetic Medicine
LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare diseases. Learn More
Imetelstat | Myelofibrosis | Myelodysplastic Syndrome | Geron
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Home | Kartos Therapeutics
Kartos Therapeutics is a clinical stage biopharmaceutical company with an investigational MDM2 inhibitor, navtemadlin (KRT-232), KRT-232
ABOUT US | Prilenia Therapeutics
Prilenia Therapeutics is a clinical stage biotech company developing its lead **** candidate, pridopidine, for Huntington’s Disease and ALS. It was founded in 2018 with the purpose of improving the lives of patients and their families by developing treatments for neurodegenerative and neurodevelopmental disorders.
Jubilant Therapeutics | Oncology | Autoimmune
As a patient-centric biopharmaceutical company, Jubilant Therapeutics leverages innovation to address unmet medical needs in oncology and autoimmune diseases.
Ocugen, Inc. – Pursuing Innovative Ocular Biotherapeutics
Ocugen, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.
Other sites like formatherapeutics com
Neurobehavioral Disorder **** Development | BlackThorn Therapeutics
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company developing novel, targeted treatments for neurobehavioral disorders. Learn more.
Tessa Therapeutics | Cancer Immunotherapy Treatments
Cure cancers with our innovative and widely accessible immunotherapies. Tessa Therapeutics is a clinical-stage biotechnology company focused on the development of autologous and allogeneic cell therapies for a broad range of cancers.
Insmed | Powered by Purpose
Insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. We are powered by purpose, with an active promise to join your fight.
Lumosa Therapeutics | Lumosa Therapeutics
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to create solution for neurological and oncological diseases with urgent unmet medical needs.
Zogenix - Therapeutic Solutions for Rare Diseases
Zogenix is committed to developing and commercializing transformative therapies to improve the lives of patients and their families living with rare diseases.
OrphoMed Inc. | Gastrointestinal Disorders | Dimer Therapeutics Platform
OrphoMed is a clinical-stage biotechnology company with a proprietary dimer therapeutics platform. The company is focused on developing best-in class treatments for patients with gastrointestinal disorders.
mRNA Therapeutics for Genetic Disease | Translate Bio
Translate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat and prevent diseases caused by protein or gene dysfunction.
Oyster Point Pharma - Therapies to Address Ophthalmic Disease
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies to address ophthalmic disease.
VectivBio | Transforming Lives
Life-Transforming Medicines for Patients Living with Severe Rare Diseases We are a global, clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions with high unmet medical need. Learn More About Us Our Focus We use a patient-centric approach to identify and develop transformative medicines for the treatment […]
Home • Arvinas
Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.
IMV Inc.
IMV Inc. is a clinical-stage biopharmaceutical company developing a new class of cancer immunotherapies and vaccines against infectious diseases
Home Page - Cancer Prevention
Cancer Prevention Pharmaceuticals is a clinical stage company developing therapeutics to reduce the risk and recurrence of cancer and rare diseases. CPP’s innovative technology addresses polyamine metabolism, immune regulation and inflammation to reduce cancer risk and impact other diseases. These … Continue reading →
G1 Therapeutics, Inc. | Optimizing Chemotherapy, Advancing Survival
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer.
Zikani Therapeutics
Zikani Therapeutics is a preclinical-stage company developing and commercializing novel therapeutics that improve the lives of patients suffering from serious,life-threatening conditions.
ViewPoint Therapeutics
ViewPoint Therapeutics is an early stage biotechnology company focused on the development of small molecule treatments for protein misfolding diseases, including cataracts and presbyopia.
Vivoryon Therapeutics - Home
Vivoryon Therapeutics is a precision medicine company focused on bringing first-in-class therapies to patients suffering from age-related diseases.
Chiasma: Empowering Lives for Everyday Living
Chiasma is a clinical-stage biopharmaceutical company dedicated to addressing the everyday challenges associated with existing therapies for rare or serious chronic diseases.
Developing novel vaccines and therapeutic proteins | Medicago
Medicago is a leading clinical-stage biopharmaceutical company using disruptive plant-based and virus-like particle (VLP) technologies to rapidly develop innovative vaccines and protein-based therapeutics for infectious diseases and emerging public health challenges.
QED Therapeutics | Targeting FGFR-driven Diseases
QED Therapeutics is a biopharma company committed to finding solutions to FGFR-driven cancers and diseases in order to give patients more possibilities.
Phathom Pharmaceuticals – Leading the way to innovative treatments for gastrointestinal diseases
A late clinical-stage biopharmaceutical company committed to transforming the treatment landscape for people suffering from GI diseases related to acid.
What else formatherapeutics.com alternative websites
BirchBioMed | Anti-scarring | Auto-immune Therapeutics | Transplantation
A clinical-stage biomedical company focused on clinical evaluation, development and commercialization of anti-scarring drugs and autoimmune therapeutics.
Odonate Therapeutics™
Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer
Caribou Biosciences | Developing Sophisticated Allogeneic Cell Therapies
Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for devastating human diseases.
Ikena Oncology | Biomarker-Driven Cancer Therapeutics
Ikena Oncology is a clinical-stage biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for cancer patients.
Author: Walid
Seres Therapeutics
We're transforming the lives of patients worldwide with revolutionary microbiome therapeutics
QUORUM INNOVATIONS | Microbiome & Biofilm Therapeutics
Quorum Innovations is a biopharmaceutical company focused on discovering and developing human microbiome therapeutics.
Bringing ingenuity to drugdevelopment
Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers.
We build superior ADCs | Iksuda Therapeutics
Iksuda is an emerging biotechnology company focused on developing antibody-based therapies for the treatment of cancer as well as broader based therapeutics. Our main goal is to develop effective therapies to improve patients’ lives. Our mission is to enable improved clinical regimes through cre ...
Author: Base Creative
I-Mab Biopharma | Bringing Transformational Medicines to Patients Through Innovation
I-Mab is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class and best-in-class biologics to treat cancers and autoimmune diseases.
AzurRx BioPharma
AzurRx BioPharma is a development stage biopharmaceutical company (NASDAQ: AZRX) focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions. Our therapeutic products will be administered to patients as **** non-systemic biologics.
Late-Stage Biopharmaceutical Company | Soligenix
Soligenix is a late-stage biopharmaceutical company that develops and commercializes products that treat rare diseases.
Kezar Life Sciences, Inc. (KZR)
Kezar Life Sciences is a clinical-stage biotechnology company committed to revolutionizing treatments for patients with autoimmune diseases and cancer.
Breakthrough miRNA therapeutics tackling cancer - InteRNA Technologies
A Dutch clinical-stage biotech company InteRNA Technologies is a Dutch clinical-stage biotech company developing a pipeline of proprietary RNA therapeutics targeting key processes in initiation and progression of human diseases, with a focus on cancer. Selected through its leading microRNA (miRNA) discovery and functional validation technology platform and enabled with a 3rd-generation **** delivery
Oncternal Therapeutics | Home
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.
NS Pharma - Building A Healthier Future Powered by Science
NS Pharma is a highly focused, research-driven biopharmaceutical company working in rare diseases.
Harpoon Therapeutics | Immuno-oncology | TriTAC™
Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases.
Altimmune a clinical stage biopharmaceutical company
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B, and conjugated immunostimulants for the treatment of cancer. In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.
Home - Epizyme
Epizyme is a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer
Home - Khondrion
Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease.
Home - GammaDelta Therapeutics
OUR MISSION Discover GammaDelta Therapeutics GammaDelta Therapeutics is committed to transforming the treatment of patients living with haematological and solid cancers. Our mission is to develop the first effective off the shelf cancer therapy based on one of the body’s own immune cells, a subtype of gamma delta (γδ) T lymphocyte known as
Author: Gammadelta
Other websites similar as formatherapeutics.com
Oculis |
Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back- and front-of-the-eye in order to improve the sight and the lives of patients worldwide.
Sutura Therapeutics
At Sutura Therapeutics we are driven to deliver innovative approaches to address current clinical translational bottlenecks in order to positively impact rare and age-related diseases.
Viridian Therapeutics, Inc.
Viridian Therapeutics is a biotechnology company advancing new treatments for patients with diseases that are underserved by today’s therapies.
Alnylam® Pharmaceuticals—The Leading RNAi Therapeutics Company
Alnylam is leading the translation of RNA interference (RNAi) into a innovative, entirely new class of medicines which we believe have the potential to transform the lives of patients who are living with rare and genetic diseases.
QOL Medical: Changing Lives
QOL Medical is a specialty biopharmaceutical company dedicated to improving the quality of life for patients with rare diseases. Learn more here.
Home | Vescor Therapeutics
We are a preclinical company focused on the discovery and development of autophagy targeted therapeutics for cancer treatment. Contact us.
Home - Akebia Therapeutics
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
Home | Cellectis
Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer
Home - Lipocine
IMPROVED **** ABSORPTION | BETTER PATIENT COMPLIANCE Improving Health We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine … Home Read More »
Home - Alkahest
Alkahest is a clinical stage biopharmaceutical company targeting neurodegenerative and age-related diseases with transformative therapies derived from a deep understanding of the plasma proteome in aging and disease. Harnessing Chronokines Aging is the dominant risk factor in degenerative diseases, particularly those with no or few therapeutic solutions. Alkahest is decoding the plasma proteome to create …
Egetis Therapeutics
Egetis is an innovative, unique, and integrated pharmaceutical **** development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan **** segment
Glycadia Pharmaceuticals – Glycadia Pharmaceuticals
Commitment to Discovery Glycadia is a clinical-stage biopharmaceutical company developing therapeutics for the prevention and treatment of kidney, eye, cardiovascular and related diseases that result from diabetes. Learn More Focus and Market The current approach to
Author: Gp J
Molecular Templates, Inc. (MTEM)
Molecular Templates is a clinical-stage biopharmaceutical company developing engineered toxin bodies (ETBs) for the treatment of cancers.
Oncopeptides
Oncopeptides is a rapidly growing biotech company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The company is science driven and committed to bringing innovation to patients with an unmet medical need and improving patient lives.
Some websites with similar theme to formatherapeutics.com include:
Personal and Business Banking - Avidia Bank
Avidia Bank is a mutual community bank headquartered in Hudson, MA that provides personal and business banking services.
Glenmede
Glenmede has a history of building enduring relationships with clients. We aspire to surpass their expectations through sophisticated investment strategies, strong technical expertise and a personalized approach. Our firm offers an ideal combination of size and strength, with integrated teams of trusted experts to meet the distinct needs of individuals and families, institutional investors, nonprofits and foundations.
A Smarter Path to Growth - BrainSell
BrainSell specialize in helping companies position their people, processes, and technology to drive smarter business growth.
Author: Trevor McSwain; Regional Sales Manager; Tetley Harris
Slane
With our signature triple casked blend Slane Irish Whiskey celebrates the return of exceptional whiskey to Ireland's Boyne Valley.
Boston Website & App Developers - Digital Marketing Agency
We build digital products & partnerships that last, and believe success in technology and business requires integrity, humility, and respect for others.
ALKU
Top-tier technology staffing provider to the world’s most innovative teams and organizations.
Korbel California Champagne
Lively, effervescent, and vibrant—there’s a lot packed into every bottle of Korbel California Champagne.
